https://www.selleckchem.com/pr....oducts/PHA-739358(Da
predictive value in a longitudinal study and to attempt to apply the LCAS to assess a broader range of subjects in a wider range of settings. Vitamin K antagonists (VKA) remain the most frequently prescribed oral anticoagulants worldwide despite the introduction of non-vitamin K antagonist oral anticoagulants (NOAC). VKA interfere with the regeneration of Vitamin K1 and K2, essential to the activation of coagulation factors and activation of matrix-Gla protein, a strong inhibitor of arterial calcifications. This study aim
Like
Comment
Share
